Prostate zones and cancer: lost in transition?
- PMID: 34667303
- DOI: 10.1038/s41585-021-00524-7
Prostate zones and cancer: lost in transition?
Abstract
Localized prostate cancer shows great clinical, genetic and environmental heterogeneity; however, prostate cancer treatment is currently guided solely by clinical staging, serum PSA levels and histology. Increasingly, the roles of differential genomics, multifocality and spatial distribution in tumorigenesis are being considered to further personalize treatment. The human prostate is divided into three zones based on its histological features: the peripheral zone (PZ), the transition zone (TZ) and the central zone (CZ). Each zone has variable prostate cancer incidence, prognosis and outcomes, with TZ prostate tumours having better clinical outcomes than PZ and CZ tumours. Molecular and cell biological studies can improve understanding of the unique molecular, genomic and zonal cell type features that underlie the differences in tumour progression and aggression between the zones. The unique biology of each zonal tumour type could help to guide individualized treatment and patient risk stratification.
© 2021. Springer Nature Limited.
References
-
- Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021). - PubMed
-
- Cancer Research UK. Prostate cancer statistics. Cancer Research UK https://www.cancerresearchuk.org/health-professional/cancer-statistics/s... (2021).
-
- NIH. Surveillance, Epidemiology, and End Results (SEER) Program. NIH https://seer.cancer.gov/statfacts/html/prost.html (2021).
-
- D’Amico, A. V. et al. 5 year biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. Int. J. Radiat. Oncol. 42, 301 (1998).
-
- Mohler, J. L. et al. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J. Natl Compr. Cancer Netw. 17, 479–505 (2019).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
